Author:
Beedle Aaron M,McRory John E,Poirot Olivier,Doering Clinton J,Altier Christophe,Barrere Christian,Hamid Jawed,Nargeot Joel,Bourinet Emmanuel,Zamponi Gerald W
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Beedle, A.M. & Zamponi, G.W. Modulation of high voltage–activated calcium channels by G protein–coupled receptors. in Calcium Channel Pharmacology (ed., McDonough, S.) (Kluwer Academic/Plenum Publishing, New York, 2003).
2. Bunzow, J.R. et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 347, 284–288 (1994).
3. Bertorelli, R. et al. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain. Br. J. Pharmacol. 128, 1252–1258 (1999).
4. Ahmadi, S., Liebel, J.T. & Zeilhofer, H.U. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin. Eur. J. Pharmacol. 412, 39–44 (2001).
5. Mollereau, C., Moisand, C., Butour, J.L., Parmentier, M. & Meunier, J.C. Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids. FEBS Lett. 395, 17–21 (1996).
Cited by
122 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献